361 related articles for article (PubMed ID: 22923001)
1. Strategies for the treatment of restless legs syndrome.
Buchfuhrer MJ
Neurotherapeutics; 2012 Oct; 9(4):776-90. PubMed ID: 22923001
[TBL] [Abstract][Full Text] [Related]
2. Restless legs syndrome: pathophysiology and modern management.
Nagandla K; De S
Postgrad Med J; 2013 Jul; 89(1053):402-10. PubMed ID: 23524988
[TBL] [Abstract][Full Text] [Related]
3. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group.
Garcia-Borreguero D; Kohnen R; Silber MH; Winkelman JW; Earley CJ; Högl B; Manconi M; Montplaisir J; Inoue Y; Allen RP
Sleep Med; 2013 Jul; 14(7):675-84. PubMed ID: 23859128
[TBL] [Abstract][Full Text] [Related]
4. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.
Garcia-Borreguero D; Silber MH; Winkelman JW; Högl B; Bainbridge J; Buchfuhrer M; Hadjigeorgiou G; Inoue Y; Manconi M; Oertel W; Ondo W; Winkelmann J; Allen RP
Sleep Med; 2016 May; 21():1-11. PubMed ID: 27448465
[TBL] [Abstract][Full Text] [Related]
5. A method to switch from oral dopamine agonists to rotigotine in patients with restless legs syndrome and mild augmentation.
Winkelman JW; Mackie SE; Mei LA; Platt S; Schoerning L
Sleep Med; 2016 Aug; 24():18-23. PubMed ID: 27810181
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapy for restless legs syndrome.
Ferini-Strambi L; Marelli S
Expert Opin Pharmacother; 2014 Jun; 15(8):1127-38. PubMed ID: 24745717
[TBL] [Abstract][Full Text] [Related]
7. From bench to bedside: An overview of rotigotine for the treatment of restless legs syndrome.
Bogan RK
Clin Ther; 2014 Mar; 36(3):436-55. PubMed ID: 24636821
[TBL] [Abstract][Full Text] [Related]
8. Restless legs syndrome in the older adult: diagnosis and management.
Milligan SA; Chesson AL
Drugs Aging; 2002; 19(10):741-51. PubMed ID: 12390051
[TBL] [Abstract][Full Text] [Related]
9. Restless legs syndrome-current therapies and management of augmentation.
Trenkwalder C; Winkelmann J; Inoue Y; Paulus W
Nat Rev Neurol; 2015 Aug; 11(8):434-45. PubMed ID: 26215616
[TBL] [Abstract][Full Text] [Related]
10. Restless legs syndrome: clinical presentation diagnosis and treatment.
Wijemanne S; Jankovic J
Sleep Med; 2015 Jun; 16(6):678-90. PubMed ID: 25979181
[TBL] [Abstract][Full Text] [Related]
11. Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations.
Geyer J; Bogan R
Postgrad Med; 2017 Sep; 129(7):667-675. PubMed ID: 28818004
[TBL] [Abstract][Full Text] [Related]
12. Management of treatment failure in restless legs syndrome (Willis-Ekbom disease).
Garcia-Borreguero D; Cano-Pumarega I; Marulanda R
Sleep Med Rev; 2018 Oct; 41():50-60. PubMed ID: 29602660
[TBL] [Abstract][Full Text] [Related]
13. A mixed treatment comparison of gabapentin enacarbil, pramipexole, ropinirole and rotigotine in moderate-to-severe restless legs syndrome.
Sun Y; van Valkenhoef G; Morel T
Curr Med Res Opin; 2014 Nov; 30(11):2267-78. PubMed ID: 25050588
[TBL] [Abstract][Full Text] [Related]
14. Non-dopaminergic vs. dopaminergic treatment options in restless legs syndrome.
Wanner V; Garcia Malo C; Romero S; Cano-Pumarega I; García-Borreguero D
Adv Pharmacol; 2019; 84():187-205. PubMed ID: 31229171
[TBL] [Abstract][Full Text] [Related]
15. French consensus: Treatment of newly diagnosed restless legs syndrome.
Limousin N; Flamand M; Schröder C; Charley Monaca C
Rev Neurol (Paris); 2018; 174(7-8):515-521. PubMed ID: 30054010
[TBL] [Abstract][Full Text] [Related]
16. Treating Severe Refractory and Augmented Restless Legs Syndrome.
Winkelman JW
Chest; 2022 Sep; 162(3):693-700. PubMed ID: 35609673
[TBL] [Abstract][Full Text] [Related]
17. Role of dopamine receptor agonists in the treatment of restless legs syndrome.
Happe S; Trenkwalder C
CNS Drugs; 2004; 18(1):27-36. PubMed ID: 14731057
[TBL] [Abstract][Full Text] [Related]
18. What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications.
Hornyak M; Scholz H; Kohnen R; Bengel J; Kassubek J; Trenkwalder C
Sleep Med Rev; 2014 Apr; 18(2):153-64. PubMed ID: 23746768
[TBL] [Abstract][Full Text] [Related]
19. High national rates of high-dose dopamine agonist prescribing for restless legs syndrome.
Winkelman JW
Sleep; 2022 Feb; 45(2):. PubMed ID: 34417810
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacology and efficacy of rotigotine (Neupro® patch) in the treatment of restless leg syndrome.
Ferini-Strambi L; Marelli S; Galbiati A
Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):967-75. PubMed ID: 27224246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
